The National Institutes of Health is permanently closing one of two pharmacies that had issues with sterility processes, according to an article on The Wall Street Journal website.
The facilities received critical reports of their sterility processes a year ago from the Food and Drug Administration.
Both facilities are located in the NIH Clinical Center, which largely treats patients who are entered in clinical studies.
An FDA inspection in May 2015 found what the agency termed “significant violations of current good manufacturing practice” at the PDS, such as failing to thoroughly investigate discrepancies in drug batches.
Making Multi-Site Lighting Upgrades Work
Designing a Positive Care Destination for Children
Blackbird Health Opens 10th Clinic in Pennsylvania
Healthcare Construction Infection Control: Essential CDC Guidelines for Active Facilities
Protecting the Most Vulnerable: Inside the NICU